Are Pharmaceutical Stocks Ready to Take Off? Here's What I See

After rough years for pharmaceutical stocks, is now a prime time to buy in? Until very recently, the stocks of America's most-hated industry — prescription drugs, of course — had been having a rough time. While the S&P 500 index was notching a return, including dividends, of well over 200% during the nine years that ended June 30, 2025, the S&P Pharmaceuticals Select Industry index eked out a mid-single-digit showing [1].

Sources

1. kiplinger.com · Are Pharmaceutical Stocks Ready to Take Off? Here's What I See Sep 8, 2026

This is the neutral brief the press writes once, for everyone, before each reader’s paper adds its own so-what. It links out; it does not republish. 1 article clustered.

Print your own paper